If deemed medically necessary, many GLP-1 medications are often covered by insurance
Canada approved its first generic semaglutide injection for weight loss from Canadian-based Apotex in June
Sikiri P, Seiwerth S, Dekovi S, Grabarevi Z, Marovi A, Ruman R, et al
Medical weight loss programs are one of the most effective and sustainable ways to help patients return to a healthy weight, significantly reducing their risks of developing weight-related health conditions
What Rybelsus is, and What it Does Rybelsus contains semaglutide, the same active ingredient found in Ozempic and injectable Wegovy
The recommended range for researchers on GLP-1 medications is 1.6-2.2 grams per kilogram of body weight daily